期刊文献+

不同检测系统测定纤维蛋白原结果的可比性分析 被引量:2

下载PDF
导出
摘要 目前,大多数中型以上医院临床实验室拥有两台或多台血凝分析系统,用于检测纤维蛋白原(fibrinogon,Fib)。不同型号的血凝分析仪使用不同的试剂、定标血浆和质控血浆,各自成为一个独立的检测系统。如何实现对Fib在不同检测系统测定结果的可比性是质量控制的最终目的。现对ACL-8000和Sysmex CA-50血凝分析仪所测Fib的结果进行对比分析,报道如下。
作者 鞠萍 张茂海
出处 《国际检验医学杂志》 CAS 2010年第2期195-195,198,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献4

二级参考文献20

  • 1彭黎明,王鸿利.我国血液病实验室诊断的若干问题[J].中华检验医学杂志,2004,27(7):401-402. 被引量:14
  • 2陈铭生,王勤富,刘中令.国产北加ApoAⅠ、ApoB参考品的WHO-IFCC靶值转移实验研究[J].国外医学(临床生物化学与检验学分册),2004,25(6):571-573. 被引量:5
  • 3徐宁,黄宪章,庄俊华,张秀明,梁伟雄.不同检测系统凝血三项测定结果的可比性研究[J].微循环学杂志,2005,15(3):50-52. 被引量:11
  • 4Day HJ, Arkin CF, Bovill EG, et al. Procedure for the determination of fibrinogen in plasma[S]. H30-A NCCLS, 1994,14.
  • 5Palareti G, Maeeaferri M, Manotti C, et al. Fibrinogen assays: a collaborative study of six different methods[J]. Clin Chem, 1991,37.714-719.
  • 6Westgard JM, Klee GG. Quality management. In: clinical diagnosis and management by laboratory methods, edited by Henry JB.19th edition. New York:John Wiley Sons, 1998.384-419.
  • 7Laboratory Standards National Committee of Clinical NCCLS. Method comparison and bias estimation using patient samples; Approved guideline.2nd edition.Wayne.Pennsylvania:NCCLS,2002.Ep9-A2.
  • 8Laboratory Standards National Committee of Clinical.NCCLS. Calibration and quality control of automated hematology analyzer; Aproved guideline.Wayne.Pennsylvania:NCCLS,1999. H38-P.
  • 9CLSI.Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline Second Edition.EP9-A2,2002,22(19):1~52.
  • 10CLSI.Evaluation of precision performance of qualitative measurement methods Approved Guideline-Second Edition.EP5-A2,2004,24(25):1~38.

共引文献63

同被引文献34

  • 1高加良,周琼秀,丁显平.血小板配型在临床血小板输注无效中的应用[J].国际检验医学杂志,2006,27(12):1152-1152. 被引量:10
  • 2李执如,廉维,宿兰.血小板抗原多态性和配型输注[J].现代临床医学,2007,33(2):143-145. 被引量:2
  • 3Metcalfe P,Watkins NA,Ouwehand WH,et al.Nomenclature of human platelet antigens[J].Vox Sang,2003,85(3):240-245.
  • 4Clinical and Laboratory Standards Institute.H57-A Protocol for the evaluation,validation,and implementation of coagulometers;approved guideline[S].Wayne,PA:CLSI,2008.
  • 5Clinical and Laboratory Standards Institute.P7-A2 Interference testing in clinical chemistry; approved guideline-second edition[S].Wayne,PA:CLSI,2005.
  • 6Clinical and Laboratory Standards Institute.AUTO 8-A Managing and validating laboratory information systems; approved guideline[S].Wayne,PA:CLSI,2006.
  • 7Clinical and Laboratory Standards Institute.GP19-A2 Laboratory instruments and data management systems:design of software.User Interfaces and end-user software systems validation,operation,and monitoring; approved guideline-second edition[S].Wayne,PA:CLSI,2003.
  • 8Clinical and Laboratory Standards Institute.H49-A Point-of-care monitoring of anticoagulation therapy; approved guideline[S].Wayne,PA:CLSI,2004.
  • 9U.S.Department of Health and Human Services.Guideline for isolation precautions:preventing transmission of infectious agents in healthcare settings 2007[EB/OL].[2007-11-27].http://www.guideline.gov.
  • 10Clinical and Laboratory Standards Institute.M29-A3 Protection of laboratory workers from occupationally acquired infections;approved guideline-third edition[S].Wayne,PA:CLSI,2005.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部